
Aziyo Biologics AZYO
Annual report 2025
added 03-13-2026
Aziyo Biologics Interest Expense 2011-2026 | AZYO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Aziyo Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.76 M | 1.19 M | 5.8 M | 5.12 M | 5.32 M | 5.63 M | 5.38 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.8 M | -2.76 M | 3.67 M |
Quarterly Interest Expense Aziyo Biologics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -1.44 M | -105 K | - | -257 K | 1.44 M | -758 K | 1.52 M | 1.43 M | - | 1.25 M | 1.2 M | 1.22 M | - | 1.33 M | 1.35 M | 1.36 M | - | 1.46 M | 1.41 M | 1.37 M | - | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.52 M | -1.44 M | 884 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.03 | 1.19 % | $ 1.66 B | ||
|
AxoGen
AXGN
|
167 K | $ 32.49 | 1.67 % | $ 1.5 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 175.31 | 1.25 % | $ 13.1 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.36 | 1.56 % | $ 1.67 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 282.75 | 1.3 % | $ 7.98 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.32 | 0.61 % | $ 124 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 38.08 | 1.3 % | $ 5.67 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 62.05 | 0.47 % | $ 91.9 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.15 | 5.53 % | $ 259 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 24.32 | 0.83 % | $ 206 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.88 | -0.49 % | $ 1.14 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.53 | 3.08 % | $ 174 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.43 | 2.88 % | $ 385 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 63.3 | 0.82 % | $ 3.45 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.85 | 2.63 % | $ 70 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 91.35 | 1.08 % | $ 12.4 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.14 | 0.98 % | $ 876 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.24 | 1.99 % | $ 367 M | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | 0.59 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 54.15 | 0.28 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.61 | -0.35 % | $ 1.14 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 85.19 | 0.06 % | $ 2.96 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.63 | -0.29 % | $ 122 M |